Ethics approval and consent to participate
HSP
HSP

Our study was approved by the Research and Ethics Committee of the Uganda Virus Research Institute (GC/127/19/09/743), the Uganda National Council for Science and Technology (HS 2714) and the Ethics Committee of the London School of Hygiene and Tropical Medicine (17914).
Participants read or were read to the appropriate participant information and consent form (ICF) to acquaint themselves with what the current study entailed and what was required of them to participate. Both verbal and written informed consent was obtained from all participants in this study. This was documented on the ICF by the participant’s own signature. If the participant was not able to read or write, a thumb print was obtained from them instead, in the presence of a competent independent witness. The witness also under-wrote and signed on that participant’s behalf. All study consent procedures were approved by the Research and Ethics Committee of the Uganda Virus Research Institute and the Ethics Committee of the London School of Hygiene and Tropical Medicine.
Research on human subjects or material or data in this study was conducted in compliance the Declaration of Helsinki and followed Human Subject Protection (HSP) principles and Good Clinical Practice (GCP) guidelines. All study methods were carried out in accordance with relevant guidelines and regulations and approved by both the Research and Ethics Committee of the Uganda Virus Research Institute and the Ethics Committee of the London School of Hygiene and Tropical Medicine. All study staff were also HSP and GCP trained.Patients with uncontrolled NCDs detected during the survey were jointly discussed with the healthcare provider at their respective facility to ensure that they receive adequate care.